IRADIMED CORPORATION (IRMD) Return on equity 2016–2025
IRADIMED CORPORATION (IRMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
23.8%FY2025 · since FY2016: 22.6% → 23.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 23.8% | +1.6 pp |
| FY2024 | 22.2% | -1.9 pp |
| FY2023 | 24.1% | +6.7 pp |
| FY2022 | 17.4% | +4.5 pp |
| FY2021 | 12.9% | +10.7 pp |
| FY2020 | 2.2% | -15.1 pp |
| FY2019 | 17.3% | +2.3 pp |
| FY2018 | 15.0% | +13.5 pp |
| FY2017 | 1.5% | -21.1 pp |
| FY2016 | 22.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More IRMD financial trends
IRMD RevenueIRMD Net incomeIRMD Net marginIRMD Gross profitIRMD Gross marginIRMD Operating incomeIRMD Operating marginIRMD Operating cash flowIRMD Free cash flowIRMD Capital expendituresIRMD Stock buybacksIRMD Dividends paidIRMD Total assetsIRMD Total liabilitiesIRMD Shareholders’ equityIRMD overview →